Navigation Links
Hospital to Hold MRSA Briefing for Media and Community Leaders
Date:10/30/2007

Dr. James Rahal, Infectious Disease Specialist, also available as Expert Resource

FLUSHING, N.Y., Oct. 30 /PRNewswire-USNewswire/ -- The following is being issued by New York Hospital Queens:

WHAT: A special briefing on methicillin-resistant Staphylococcus

aureus(MRSA) is scheduled for media and community leaders.

James Rahal, M.D., and a team of infectious disease

specialists from New York Hospital Queens will address the

basis of concern about this infection. They will discuss the

risks, and address the fear caused by recent cases of

community-acquired MRSA infection in the New York area.

During the briefing, the date and location of a community

education program is expected to be announced.

WHEN: Thursday, November 1, 2007 at 10 a.m.

WHERE: New York Hospital Queens 56-45 Main Street, Flushing NY

11355

Lang Auditorium (please leave 15 minutes for access from

parking area)

FYI: Methicillin-resistant Staphylococcus aureus (MRSA) is a type

of Staph that is resistant to commonly used antibiotics. MRSA

infections occur most frequently among persons in hospitals

and healthcare facilities (such as nursing homes and dialysis

centers) who have weakened immune systems.

MRSA infections that are acquired by healthy persons in the

community who have not been recently (within the past year)

hospitalized or had a medical procedure are known as

Community Acquired-MRSA infections (CA-MRSA). These CA-MRSA

infections are usually manifested as skin infections, such as

pimples, boils, or abscesses; and rarely, pneumonia. For

ba
'/>"/>

SOURCE New York Hospital Queens
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
4. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
5. Nektar Threraputics Announces Phase 2a Clinical Results Regarding the use of NKTR-061 (Inhaled Amikacin) to Treat Gram-Negative Hospital-Acquired Pneumonia Presented at the Annual American Thoracic Society International Conference
6. Six Important Things to Know About Preventing Hospital Infections
7. Lipitor Significantly Lowered Hospitalization Costs for Patients with Heart Disease, Two New Analyses Show
8. Hospitalization Rates for Coronary Artery Disease Decline in the U.S.
9. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
10. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
11. OREXIGEN Therapeutics Announces Sustained-Release Formulation of Zonisamide Shows Improved Tolerability When Compared to Immediate Release Formulation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... YORK, Dec. 3 Alzheimer,s disease ...person can receive. This irreversible, progressive... skills and eventually even the ability to carry o...mentia among older people, AD affects as many as 2...the National Institute on Aging. ,, (Logo: h...
(Date:12/3/2009)...ON, Texas, Dec. 3 ULURU... Medical-Surgical, Inc., one of the major pharmace...oved ULURU Inc. to be one of its suppliers and has...TM). McKesson Medical-Surgical delivers a comprehe...al equipment and health care technology-related se...
(Date:12/3/2009)...ISCATAWAY, N.J., Dec. 3 ...S), the recognized leader in advanced injection te...to a joint venture with China National Medicines C...manwell Pharmaceutical Co. Ltd., both incorporated... develop orthopedic and epidural drug delivery ins...
Breaking Medicine Technology:Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3ULURU Inc. Obtains Status of Approved Supplier With McKesson. 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 2Milestone Scientific to Establish Joint Venture to Develop Medical Drug Delivery Instruments 3Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 1Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 2Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 3Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 4Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 5Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 6Dow AgroSciences Monsanto Complete U S and Canadian Regulatory Authorizations for SmartStax Corn 3B Plans Set to Launch Seed Platform on 3 Million 13098 7Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses 13096 1Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses 13096 2Double Helix Strengthens its Strategic Pricing and Reimbursement Practice with Hire of Caryn Zieses 13096 3Idenix Pharmaceuticals Successfully Completes Proof of Concept Study of IDX184 for the Treatment of Hepatitis C Virus 28HCV 29 4752 1Idenix Pharmaceuticals Successfully Completes Proof of Concept Study of IDX184 for the Treatment of Hepatitis C Virus 28HCV 29 4752 2Idenix Pharmaceuticals Successfully Completes Proof of Concept Study of IDX184 for the Treatment of Hepatitis C Virus 28HCV 29 4752 3Idenix Pharmaceuticals Successfully Completes Proof of Concept Study of IDX184 for the Treatment of Hepatitis C Virus 28HCV 29 4752 4Idenix Pharmaceuticals Successfully Completes Proof of Concept Study of IDX184 for the Treatment of Hepatitis C Virus 28HCV 29 4752 5
(Date:12/3/2009)... , PASADENA, Calif., Dec. 3 F...inesses, the risk of disability remains one of the...al financial well being, but also their business,s...clines have taken their toll, owners of small busi...financial safety net with enhanced disability cove...
(Date:12/3/2009)...Hughes Medical Institute (HHMI) researchers have i...evelopment of many forms of medulloblastoma, the m...r., HHMI investigator Huda Y. Zoghbi and colleag...oblastoma from developing in mice by shutting down...ain cells. The team,s findings, reported in the De...
(Date:12/3/2009)... , Massachusetts Does Little to Make Lung Ca...GTON, Dec. 3 Today, L...its 3rd Annual Report Card on Lung Cancer . The ...g made against this lethal disease in the state of...r Alliance (LCA), the only national organization d...
(Date:12/3/2009)... , More than 1,500 Jobs Listed through APHA...Dec. 3 Today,s White Ho...ployment across many professions, including public... the need and connect job seekers to more than 1,5...areerMart at http://www.apha.org/about/careers/ ...
(Date:12/3/2009)...K (December 3, 2009) -- When the heart is stopped ... their brain is often permanently damaged. Therape...,s body temperature is lowered and maintained seve... been shown to mitigate these harmful effects and ...large-scale multicenter study of its kind, physici...
Breaking Medicine News(10 mins):Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Researchers identify gene that spurs deadly brain cancer 2Health News:Researchers identify gene that spurs deadly brain cancer 3Health News:Lung Cancer Alliance-Massachusetts Releases 3rd Annual State-Specific Report Card on Lung Cancer 2Health News:Public Health Jobs Site Available to Help Meet Growing Demand 2Health News:Cooling may benefit children after cardiac arrest 2
...us system cells that support brain function, study...ews) -- The impact of amyloid plaques in the brain...omplex than believed, U.S. researchers report. , I...d that amyloid plaques may also increase the activ...
...r of Americans traveling abroad for healthcare is ...mer trend as the recession worsens and more Americ... medical bills at U.S. hospitals. , , According t...on by 2017. The $16 billion in cross border revenu...
...ch suggests taking proper care of your teeth and g... Here,s more on the emerging association between o...eport from Colgate-Palmolive at: http://inr.media...unrestricted use at http://www.mediaseed.tv . , ...
...s years teaching and mentoring young orthopaedic s...ucation in underserved communities and helping col...he long list of achievements that led to Blair C. ...esented to Dr. Filler at the American Academy of O...
...it was filed today by Latherow Law,Office on behal...oisoning,after eating at a Blueberry Hill Restaura... child was hospitalized for three days as a result... also,contracted salmonella poisoning after eating...
...S Caremark Corporation (NYSE: CVS ) today announ...Chief Financial Officer and Chief Administrative O... at the Raymond James Institutional Investors Conf...6/NE75914LOGO ) , , An audio webcast of the pres...
Other Medicine News:Health News:Alzheimer's Plaques More Complex Than Thought 2Health News:Americans Will Soon Have Medical Butlers to Assist in Medical Tourism Research 2Health News:Blair C. Filler, M.D. Receives 2009 Tipton Award for Outstanding Orthopaedic Leadership 2Health News:Blair C. Filler, M.D. Receives 2009 Tipton Award for Outstanding Orthopaedic Leadership 3Health News:CVS Caremark Corporation to Present at the Raymond James Institutional Investors Conference on March 10th 2
...ng (ACB®) Test is a clinical chemistry assay t...y measuring the cobalt binding capacity of albumin...e early 1990s, IMA is produced when circulating al... heart. During ischemia, the N-terminus of albumin...
...ng (ACB®) Test is a clinical chemistry assay t...y measuring the cobalt binding capacity of albumin...e early 1990s, IMA is produced when circulating al... heart. During ischemia, the N-terminus of albumin...
...ng (ACB®) Test is a clinical chemistry assay t...y measuring the cobalt binding capacity of albumin...e early 1990s, IMA is produced when circulating al... heart. During ischemia, the N-terminus of albumin...
...its that quantitatively measure two important card.... An elevated serum or plasma homocysteine level i...risk factor for cardiovascular disease. And numero...levated levels of Lp(a) with increased risk of cor...
Medicine Products: